Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Redx Pharma Plc Shares now trading on JP Jenkins

1 May 2024 07:04

JP Jenkins Ltd Redx Pharma Plc Shares now trading on JP Jenkins 01-May-2024 / 07:03 GMT/BST The issuer is solely responsible for the content of this announcement.


1st May 2024

JPJ: REDX

ISIN: GB00BSNB6S51

Redx Pharma Plc

 

Shares now trading on JP Jenkins

 

 

Alderley Park, 1st May 2024 - Shares in Redx Pharma Plc (“Redx”) (https://www.redxpharma.com/) have been admitted to trade on JP Jenkins share dealing platform. Redx is based at Block 33 Mereside, Alderley Park, Macclesfield, England, SK10 4TG and is registered as a company in England and Wales under Companies House, company number 07368089.

 

Redx (JPJ: REDX) is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, targeted therapeutics for the treatment of fibrotic disease and cancer.

 

JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).

 

Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.

 

The indicative pricing for the ordinary shares (ISIN: GB00BSNB6S51), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/)

 

Peter Collum, Chief Financial Officer, Redx Pharma said “We are pleased to be able to offer our shareholders the ability to continue trading Redx shares on the JP Jenkins platform as a private company following the delisting from AIM. The JP Jenkins platform allows buying and selling of shares through a structured secondary market using brokers in the same manner as trading a listed security. This will allow us to focus on the execution of our corporate strategy, driving forward our pipeline of differentiated, novel drug candidates and ultimately delivering shareholder returns.

 

Veronika Oswald, Commercial Director of JP Jenkins said: “Red’s move from AIM to the JP Jenkins venue represents a significant step forward in our journey towards accessibility and liquidity for their investors. This transition underscores our commitment to fostering a dynamic and thriving investment environment. We're thrilled to embark on this new chapter with Redx, confident in the opportunities it will unlock for both companies."

 

For further information, please contact:

 

 

JP Jenkins Limited

Redx Pharma Plc

Contact: Veronika Oswald (Director)

Caitlin Pearson (Head of Communications)

+44 (0)20 7469 0937

01625 469 918

IR@redxpharma.com

 

 

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1893571 01-May-2024 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
5th Aug 20207:00 amRNSAppointment of NED and changes to Board committees
4th Aug 20207:37 amRNSOut licensing agreement with AstraZeneca
20th Jul 202011:35 amRNSResult of General Meeting
2nd Jul 20202:05 pmRNSSecond Price Monitoring Extn
2nd Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 202012:30 pmRNSDirector/PDMR Shareholding
30th Jun 202011:30 amRNSHolding(s) in Company
30th Jun 20207:46 amRNSShare Option Scheme
30th Jun 20207:02 amRNSInterim Results
30th Jun 20207:00 amRNSProposed financing of $30m and notice of GM
15th Jun 202011:05 amRNSSecond Price Monitoring Extn
15th Jun 202011:00 amRNSPrice Monitoring Extension
20th May 20207:00 amRNSChange of Adviser
18th May 20207:00 amRNSAppointment of Non-Executive Director
6th May 20208:45 amRNSHolding(s) in Company
5th May 20209:45 amRNSHolding(s) in Company
4th May 20209:32 amRNSForm 8.3 - [REDX PHARMA PLC]
1st May 202011:45 amRNSForm 8.5 (EPT/RI)
1st May 20207:00 amRNSOffer Closed
29th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
23rd Apr 202011:45 amRNSForm 8.5 (EPT/RI)
23rd Apr 202011:32 amRNSResult of AGM and operational update
21st Apr 202011:45 amRNSForm 8.5 (EPT/RI)
20th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
17th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
15th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
14th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
9th Apr 20206:10 pmRNSRedx Pharma
9th Apr 20204:47 pmRNSPUBLICATION OF OFFER DOCUMENT
9th Apr 20201:58 pmRNSOffer Update - Share Acquisitions
7th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
6th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
3rd Apr 20209:44 amRNSForm 8 (DD) - Redx Pharma PLC
3rd Apr 20209:27 amRNSForm 8.5 - RedX Pharma Plc
3rd Apr 20209:14 amRNSHolding(s) in Company
3rd Apr 20207:00 amRNSForm 8.3 - Redx Pharma plc
2nd Apr 20202:31 pmRNSOffer Update - Share Acquisitions
2nd Apr 202012:27 pmRNSForm 8.5 - RedX Pharma Plc
2nd Apr 202011:45 amRNSForm 8.5 (EPT/RI)
2nd Apr 202011:20 amRNSHolding(s) in Company
2nd Apr 20209:55 amRNSForm 8 (DD) - Redx Pharma PLC
1st Apr 202012:13 pmRNSForm 8.5 - Redx Pharma Plc
1st Apr 202011:01 amRNSForm 8 (DD) - Redx Pharma PLC
31st Mar 20207:00 amRNSInformation regarding Company AGM
30th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
30th Mar 20207:00 amRNS£5 million short term loan agreement
27th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
27th Mar 202011:43 amRNSForm 8 (OPD) - Redx Pharma Plc
26th Mar 20202:03 pmRNSForm 8.3 - Redx Pharma plc
26th Mar 20201:42 pmRNSForm 8.3 - Redx Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.